China greenlights three ChiNext IPOs

0 Comment(s)Print E-mail Xinhua, November 20, 2021
Adjust font size:

China's securities regulator has approved the initial public offering (IPO) registration of three companies on the country's NASDAQ-style ChiNext board.

Jiujiang Shanshui Technology Co., Ltd., Shanghai Universal Biotech Co., Ltd. and Hubei Biocause Heilen Pharmaceutical Co., Ltd. will be listed on the Shenzhen Stock Exchange's board of growth enterprises, the ChiNext board, according to the China Securities Regulatory Commission.

The companies and their underwriters will confirm the IPO dates and publish their prospectuses following discussions with the stock exchange. 

Follow China.org.cn on Twitter and Facebook to join the conversation.
ChinaNews App Download
Print E-mail Bookmark and Share

Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:   
    Racist, abusive and off-topic comments may be removed by the moderator.
Send your storiesGet more from China.org.cnMobileRSSNewsletter